These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 10837603)

  • 1. Recent advances in liposome technologies and their applications for systemic gene delivery.
    Cullis PR; Chonn A
    Adv Drug Deliv Rev; 1998 Mar; 30(1-3):73-83. PubMed ID: 10837603
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recent advances in liposomal drug-delivery systems.
    Chonn A; Cullis PR
    Curr Opin Biotechnol; 1995 Dec; 6(6):698-708. PubMed ID: 8527843
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Liposomal drug delivery systems--clinical applications.
    Goyal P; Goyal K; Vijaya Kumar SG; Singh A; Katare OP; Mishra DN
    Acta Pharm; 2005 Mar; 55(1):1-25. PubMed ID: 15907221
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Engineering liposomal nanoparticles for targeted gene therapy.
    Zylberberg C; Gaskill K; Pasley S; Matosevic S
    Gene Ther; 2017 Aug; 24(8):441-452. PubMed ID: 28504657
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Liposomes: applications in medicine.
    Banerjee R
    J Biomater Appl; 2001 Jul; 16(1):3-21. PubMed ID: 11475357
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Size dependent variations of phospholipid based vesicular drug carriers in systemic drug activity.
    Mukherjee B; Mondal L; Chakraborty S; Paul P; Choudhury A; Bhattacharya S; Hossain CM
    Curr Pharm Biotechnol; 2015; 16(4):380-91. PubMed ID: 25658382
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The liposomal formulation of doxorubicin.
    Abraham SA; Waterhouse DN; Mayer LD; Cullis PR; Madden TD; Bally MB
    Methods Enzymol; 2005; 391():71-97. PubMed ID: 15721375
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Targeted-liposome Delivery System of Antitumor Drugs.
    Wu WD; Yi XL; Jiang LX; Li YZ; Gao J; Zeng Y; Yi RD; Dai LP; Li W; Ci XY; Si DY; Liu CX
    Curr Drug Metab; 2015; 16(10):894-910. PubMed ID: 26652257
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Entrapment of small molecules and nucleic acid-based drugs in liposomes.
    Fenske DB; Cullis PR
    Methods Enzymol; 2005; 391():7-40. PubMed ID: 15721372
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interactions of liposomes and lipid-based carrier systems with blood proteins: Relation to clearance behaviour in vivo.
    Cullis PR; Chonn A; Semple SC
    Adv Drug Deliv Rev; 1998 Jun; 32(1-2):3-17. PubMed ID: 10837632
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Trends and developments in liposome drug delivery systems.
    Lian T; Ho RJ
    J Pharm Sci; 2001 Jun; 90(6):667-80. PubMed ID: 11357170
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Membrane modification by negatively charged stearyl-polyoxyethylene derivatives for thermosensitive liposomes: reduced liposomal aggregation and avoidance of reticuloendothelial system uptake.
    Iga K; Ohkouchi K; Ogawa Y; Toguchi H
    J Drug Target; 1994; 2(3):259-67. PubMed ID: 7812694
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Carbohydrate-Derived Metal-Chelator-Triggered Lipids for Liposomal Drug Delivery.
    Holmstrøm T; Galsgaard Malle M; Wu S; Jensen KJ; Hatzakis NS; Pedersen CM
    Chemistry; 2021 Apr; 27(23):6917-6922. PubMed ID: 33411939
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Liposomal nanostructures for photosensitizer delivery.
    Jin CS; Zheng G
    Lasers Surg Med; 2011 Sep; 43(7):734-48. PubMed ID: 22057501
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of liposomes as injectable-drug delivery systems.
    Ostro MJ; Cullis PR
    Am J Hosp Pharm; 1989 Aug; 46(8):1576-87. PubMed ID: 2672806
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug delivery systems. 1. site-specific drug delivery using liposomes as carriers.
    Ranade VV
    J Clin Pharmacol; 1989 Aug; 29(8):685-94. PubMed ID: 2674208
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Advanced strategies in liposomal cancer therapy: problems and prospects of active and tumor specific drug release.
    Andresen TL; Jensen SS; Jørgensen K
    Prog Lipid Res; 2005 Jan; 44(1):68-97. PubMed ID: 15748655
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Liposomes in the treatment of malignancy: a clinical perspective.
    Sugarman SM; Perez-Soler R
    Crit Rev Oncol Hematol; 1992; 12(3):231-42. PubMed ID: 1497823
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cyclic Disulfide Liposomes for Membrane Functionalization and Cellular Delivery.
    Qualls ML; Lou J; McBee DP; Baccile JA; Best MD
    Chemistry; 2022 Aug; 28(45):e202201164. PubMed ID: 35699671
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heterogeneous liposome membranes with pH-triggered permeability enhance the in vitro antitumor activity of folate-receptor targeted liposomal doxorubicin.
    Mamasheva E; O'Donnell C; Bandekar A; Sofou S
    Mol Pharm; 2011 Dec; 8(6):2224-32. PubMed ID: 21899300
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.